Regulatory/Legislative News

The FDA has cleared Allergan’s Xen glaucoma treatment system for refractory glaucoma, according to a company press release.

The FDA has cleared the PLEX Elite 9000 for advanced retina research, Carl Zeiss Meditec announced in a press release.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

In October, the FDA approved, cleared, responded to and issued review status for products and devices in the ophthalmic space. Here are the articles:

The American Medical Association Current Procedural Terminology Editorial Panel approved two new Category III CPT codes for programming the Argus II retinal prosthesis system, Second Sight Medical Products announced in a press release.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

CHICAGO — The recently finalized MACRA rule from the Centers for Medicare and Medicare Services may help ophthalmologists avoid penalties by shifting physician payments from a volume based payment program to a value based payment program, according to speakers here.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.